文献速递腹部介入技术与安全MR

治疗前MRI影像组学预测肝细胞癌经动脉化疗栓塞术后肿瘤反应与结局:一项两中心协作研究

Radiomics analysis of pretreatment MRI in predicting tumor response and outcome in hepatocellular carcinoma with transarterial chemoembolization: a two-center collaborative study.
PubMed 文献 · Abdom Radiol (NY) · 2021-12-16

该两中心回顾性研究纳入140例接受TACE的HCC患者,基于T2WI和DCE构建影像组学评分,并结合BCLC分期和ALBI分级建立逻辑回归模型预测肿瘤反应;模型在训练集AUC为0.813、测试集为0.781,LR预测的反应者与非反应者间PFS和OS存在显著差异。

要点

  • T2WI影像组学评分预测TACE后肿瘤反应性能优于DCE序列(AUC 0.754 vs 0.602至0.752)。
  • 联合T2WI影像组学评分、BCLC分期和ALBI分级的LR模型预测反应AUC训练集0.813、测试集0.781。
  • LR预测的反应者与非反应者间PFS和OS存在显著差异,Cox模型预测PFS和OS的C-index分别为0.705和0.736。

核心结论

  • 联合MRI影像组学与临床因素的模型在预测肿瘤反应和临床结局方面表现出较好性能,可能有助于个体化临床管理。

研究设计与样本

  • 两中心回顾性研究,纳入140例接受TACE的HCC患者,肿瘤反应采用mRECIST标准评估;基于T2WI和DCE分别构建影像组学评分,并与常规临床-影像变量整合建立逻辑回归模型;模型在中心1的94例患者中训练,在中心2的46例患者中独立测试。

诊断标准与关键数值

  • T2WI影像组学评分预测肿瘤反应的AUC为0.754,DCE序列AUC为0.602至0.752;联合T2WI影像组学评分、BCLC分期和ALBI分级的LR模型预测肿瘤反应AUC在训练集为0.813、测试集为0.781;Cox模型预测PFS和OS的C-index分别为0.705和0.736。

临床应用与阅片要点

  • 作者认为该联合模型可能有助于个体化临床管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND OBJECTIVE: To develop a machine-learning model by integrating clinical and imaging modalities for predicting tumor response and survival of hepatocellular carcinoma (HCC) with transarterial chemoembolization (TACE).

METHODS: 140 HCC patients with TACE were retrospectively included from two centers. Tumor response were evaluated using modified Response Evaluation Criteria in Solid Tumors (mRECIST) criteria. Response-related radiomics scores (Rad-scores) were constructed on T2-weighted images (T2WI) and dynamic contrast-enhanced (DCE) imaging separately, and then integrated with conventional clinic-radiological variables into a logistic regression (LR) model for predicting tumor response. LR model was trained in 94 patients in center 1 and independently tested in 46 patients in center 2.

RESULTS: Among 4 MRI sequences, T2WI achieved better performance than DCE (area under the curve [AUC] 0.754 vs 0.602 to 0.752). LR model by combining Rad-score on T2WI with Barcelona Clinic Liver Cancer (BCLC) stage and albumin-bilirubin (ALBI) grade resulted in an AUC of 0.813 in training and 0.781 in test for predicting tumor response. In survival analysis, progression-free survival (PFS) and overall survival (OS) presented significant difference between LR-predicted responders and non-responders. The ALBI grade and BCLC stage were independent predictors of PFS; and LR-predicted response, ALBI grade, satellite node, and BCLC stage were independent predictors of OS. The resulting Cox model produced concordance-indexes of 0.705 and 0.736 for predicting PFS and OS, respectively.

CONCLUSIONS: The model combined MRI radiomics with clinical factors demonstrated favorable performance for predicting tumor response and clinical outcomes, thus may help personalized clinical management.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Liu, Yang, Xu, et al. Radiomics analysis of pretreatment MRI in predicting tumor response and outcome in hepatocellular carcinoma with transarterial chemoembolization: a two-center collaborative study. Abdom Radiol (NY). 2021. PMID: 34918174. doi:10.1007/s00261-021-03375-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。